Viatris, Inc. (VTRS)
16.54
+0.22
(+1.38%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Viatris Net Income (Quarterly) : -118.80M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -118.80M |
| March 31, 2026 | 176.40M |
| December 31, 2025 | -340.10M |
| September 30, 2025 | -128.20M |
| June 30, 2025 | -4.60M |
| March 31, 2025 | -3.042B |
| December 31, 2024 | -516.50M |
| September 30, 2024 | 94.80M |
| June 30, 2024 | -326.40M |
| March 31, 2024 | 113.90M |
| December 31, 2023 | -765.60M |
| September 30, 2023 | 331.60M |
| June 30, 2023 | 264.00M |
| March 31, 2023 | 224.70M |
| December 31, 2022 | 1.011B |
| September 30, 2022 | 354.30M |
| June 30, 2022 | 313.90M |
| March 31, 2022 | 399.20M |
| December 31, 2021 | -263.80M |
| September 30, 2021 | 311.50M |
| June 30, 2021 | -279.20M |
| March 31, 2021 | -1.038B |
| December 31, 2020 | -915.80M |
| September 30, 2020 | 185.70M |
| June 30, 2020 | 39.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.80M |
| December 31, 2019 | 20.50M |
| September 30, 2019 | 189.80M |
| June 30, 2019 | -168.50M |
| March 31, 2019 | -25.00M |
| December 31, 2018 | 51.20M |
| September 30, 2018 | 176.70M |
| June 30, 2018 | 37.50M |
| March 31, 2018 | 87.10M |
| December 31, 2017 | 244.30M |
| September 30, 2017 | 88.30M |
| June 30, 2017 | 297.00M |
| March 31, 2017 | 66.40M |
| December 31, 2016 | 417.50M |
| September 30, 2016 | -119.80M |
| June 30, 2016 | 168.40M |
| March 31, 2016 | 13.90M |
| December 31, 2015 | 194.60M |
| September 30, 2015 | 428.60M |
| June 30, 2015 | 167.90M |
| March 31, 2015 | 56.60M |
| December 31, 2014 | 190.50M |
| September 30, 2014 | 499.40M |
| June 30, 2014 | 126.60M |
| March 31, 2014 | 116.60M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pfizer Inc. | -246.00M |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
| Bristol Myers Squibb Co. | 3.316B |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.762B |
| Total Expenses (Quarterly) | 3.881B |
| EPS Diluted (Quarterly) | -0.1021 |
| Enterprise Value | 31.07B |
| Gross Profit Margin (Quarterly) | 41.92% |
| Profit Margin (Quarterly) | -3.16% |
| Earnings Yield | -2.16% |
| Operating Earnings Yield | 7.42% |
| Normalized Earnings Yield | 3.050 |